Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Abstract 18200: Prognostic Importance of Serial NT-proBNP Measurements Following High-Risk Mi: The PARADISE-MI Trial
Karola Jering, Brian Claggett, Marc A. Pfeffer, Christopher B. Granger, Lars Køber, Eldrin F. Lewis, Aldo Maggioni, Douglas L. Mann, John J.V. McMurray, Margaret F. Prescott, Jean L. Rouleau, Scott D. Solomon, Philippe Gabríel Steg, Dirk von Lewinski, Eugene Braunwald (2023). Abstract 18200: Prognostic Importance of Serial NT-proBNP Measurements Following High-Risk Mi: The PARADISE-MI Trial. , 148(Suppl_1), DOI: https://doi.org/10.1161/circ.148.suppl_1.18200.
Article23 days agoThe Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial
Roxana Mehran, Philippe Gabríel Steg, Marc A. Pfeffer, Karola Jering, Brian Claggett, Eldrin F. Lewis, Christopher B. Granger, Lars Køber, Aldo Maggioni, Douglas L. Mann, John J.V. McMurray, Jean‐Lucien Rouleau, Scott D. Solomon, Grégory Ducrocq, Otávio Berwanger, Carmine G. De Pasquale, Ulf Landmesser, Mark C. Petrie, David Sim Kheng Leng, Peter van der Meer, Martin Lefkowitz, Yinong Zhou, Eugene Braunwald (2022). The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial. , 146(23), DOI: https://doi.org/10.1161/circulationaha.122.060841.
Article23 days agoSacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win‐ratio analysis of the PARADISE‐MI trial
Otávio Berwanger, Marc A. Pfeffer, Brian Claggett, Karola Jering, Aldo Maggioni, Philippe Gabríel Steg, Roxana Mehran, Eldrin F. Lewis, Yinong Zhou, Peter van der Meer, Carmine G. De Pasquale, Béla Merkely, Gerasimos Filippatos, John J.V. McMurray, Christopher B. Granger, Scott D. Solomon, Eugene Braunwald (2022). Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win‐ratio analysis of the PARADISE‐MI trial. , 24(10), DOI: https://doi.org/10.1002/ejhf.2663.
Article23 days agoDifferences in Characteristics and Clinical Outcomes According to Age in Patients Following High-Risk Myocardial Infarction: Insights from PARADISE-MI
Karola Jering, Brian Claggett, Offer Amir, Maja Čikeš, Marc J. Claeys, Carmine G. De Pasquale, Christopher B. Granger, Lars Køber, Ulf Landmesser, Eldrin F. Lewis, Aldo Maggioni, Béla Merkely, John J.V. McMurray, Grzegorz Opolski, Jean L. Rouleau, Michele Senni, Scott D. Solomon, Peter van der Meer, Marc A. Pfeffer (2025). Differences in Characteristics and Clinical Outcomes According to Age in Patients Following High-Risk Myocardial Infarction: Insights from PARADISE-MI. , 257, DOI: https://doi.org/10.1016/j.amjcard.2025.07.032.
Article23 days agoNT-proBNP in the Early Convalescent Phase after High-Risk Myocardial Infarction Is Associated with Adverse Cardiovascular Outcomes: the PARADISE-MI Trial
Karola Jering, Brian Claggett, Eugene Braunwald, Christopher B. Granger, Lars Køber, Ulf Landmesser, Eldrin F. Lewis, Aldo Maggioni, Douglas L. Mann, John J.V. McMurray, R. Mehran, Mark C. Petrie, Margaret F. Prescott, Jean-Lucien Rouleau, Morten Schou, Scott Solomon, Philippe Gabríel Steg, Dirk von Lewinski, Marc A. Pfeffer (2025). NT-proBNP in the Early Convalescent Phase after High-Risk Myocardial Infarction Is Associated with Adverse Cardiovascular Outcomes: the PARADISE-MI Trial. , 32(3), DOI: https://doi.org/10.1016/j.cardfail.2025.03.018.
Article23 days ago